Asia Pacific Sleep Apnea Devices Market By Product Type (Therapeutic Devices and Diagnostic Devices) By Therapeutic Devices Type (PAP Devices, Oral Devices, Nasal Devices and Chin Straps) By Diagnostic Devices Type (Polysomnography, Respiratory Polygraphs, Pulse Oximeters and Actigraphs) By Country, Industry Analysis and Forecast, 2019 - 2025
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Sleep Apnea Devices Market
Market Report Description
The Asia Pacific Sleep Apnea Devices Market would witness market growth of 8.7% CAGR during the forecast period (2019-2025). Keeping an awareness of the adverse effects of untreated sleep apnea, increased use of oral devices and the technical development of sleep apnea machines, significant venture capital funds and a rising number of firms engaged in sleep apnea and oral application are primarily important drivers of the growth market for sleep apnea devices. The incidence of sleeping apnea rises as other diseases such as hypertensions, heart diseases, diabetes and mental disorders such as depression and anxiety become more severe. Increasing awareness about the long-term effects of sleep apnea is expected to drive revenue growth in the forecast period.
The diagnosis rate of OSA in countries with large population bases, such as India and China, is < 1%. China is the main contributor to the demand for sleep apnea products in Asia-Pacific. The region's demand is driven largely by increased occupational stress and the prevalence of numerous mental health disorders such as anxiety, depression and others, which greatly raises the risk of sleep disorders. Furthermore, increasing geriatric population particularly in Japan is another major reason for rising market. Chinese teenagers have predominant sleep insufficiency, drowsiness, and insomnia.
Low understanding of sleep disorders in low-and middle-income countries, however, and strict enforcement requirements set by third-party payers leading to restricted reimbursement, are hindering market growth. Furthermore, in developing and underdeveloped countries, the discomfort caused to the user by sleeping apnea devices while sleeping and the high cost of these devices often restrict their adoption.
Based on Product Type, the market is segmented into Therapeutic Devices and Diagnostic Devices. Based on Therapeutic Devices Type, the market is segmented into PAP Devices, Oral Devices, Nasal Devices and Chin Straps. Based on Diagnostic Devices Type, the market is segmented into Polysomnography, Respiratory Polygraphs, Pulse Oximeters and Actigraphs. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Fisher & Paykel Healthcare Corporation Limited, SomnoMed Limited, Mitsui Chemical, Inc. (Whole You, Inc.), Teleflex, Inc., ResMed, Inc., Oventus Medical Ltd., Panthera Dental, Inc. (Panthera Sleep), BRAEBON Medical Corporation, and BMC Medical Co., Ltd.
Scope of the Asia Pacific Sleep Apnea Devices Market Analysis
By Product Type
- Therapeutic Devices and
- Diagnostic Devices
By Therapeutic Devices Type
- PAP Devices
- Oral Devices
- Nasal Devices and
- Chin Straps
By Diagnostic Devices Type
- Respiratory Polygraphs
- Pulse Oximeters and
- South Korea
- Rest of Asia Pacific
- Koninklijke Philips N.V.
- Fisher & Paykel Healthcare Corporation Limited
- SomnoMed Limited
- Mitsui Chemical, Inc. (Whole You, Inc.)
- Teleflex, Inc.
- ResMed, Inc.
- Oventus Medical Ltd.
- Panthera Dental, Inc. (Panthera Sleep)
- BRAEBON Medical Corporation
- BMC Medical Co., Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free